Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL461101

ELTROMBOPAG
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O

Basic Information

ChEMBL ID CHEMBL461101
Name ELTROMBOPAG
Phase Approved
Structure Type MOL
InChI Key XDXWLKQMMKQXPV-QYQHSDTDSA-N
Therapeutic ✓ Yes

Known Names

Eltrombopag Revolade SB497115
9
Targets
19
Activities
4
Assay Types
13
PK Parameters
20
Publications
3
Known Names
20
Indications

Molecular Properties

442.5
MW (Da)
4.56
ALogP
6
HBA
3
HBD
114.6
PSA (Ų)
0.40
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2008
Availability Prescription
Chirality Achiral

Routes of Administration

Oral

Flags

Black Box Warning Natural Product
USAN Stem -trombopag
USAN Year 2005

Extended Properties

Molecular Formula C25H22N4O4
MW 442.48
Aromatic Rings 3
Heavy Atoms 33
NP-Likeness -1.07

Indications

Anemia, Aplastic Anemia, Aplastic Hemorrhage Hepatitis C Hepatitis C, Chronic Neoplasms Purpura, Thrombocytopenic, Idiopathic Thrombocytopenia Blood Platelet Disorders Fanconi Anemia Graft vs Host Disease Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Myeloid, Acute Liver Diseases Lymphoma Myelodysplastic Syndromes Wiskott-Aldrich Syndrome Anemia Liver Cirrhosis

ATC Classification

B02BX05
eltrombopag
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: ANTIHEMORRHAGICS

Activity Summary

IC50 11 meas. best 6.2
Ki 4 meas. best 5.07
EC50 2 meas. best 7.42
Kd 2 meas. best 4.88

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Thrombopoietin receptor
CHEMBL1864
EC50 7.42 7.42 38.0 2
Voltage-gated inwardly rectifying potassium channel KCNH2
CHEMBL240
IC50 6.2 6.18 631.0 2
Broad substrate specificity ATP-binding cassette transporter ABCG2
CHEMBL5393
IC50 5.51 5.51 3100.0 1
METTL3/METTL14
CHEMBL4106140
IC50 5.44 5.4067 3650.0 3
SARS-CoV-2
CHEMBL4303835
IC50 5.08 5.08 8270.0 1
Solute carrier organic anion transporter family member 2B1
CHEMBL1743124
Ki 5.07 5.07 8480.0 1
METTL3/METTL14
CHEMBL4106140
Kd 4.88 4.88 13200.0 1
N6-adenosine-methyltransferase catalytic subunit
CHEMBL4739695
Kd 4.88 4.88 13200.0 1
Solute carrier organic anion transporter family member 1B1
CHEMBL1697668
Ki 4.83 4.83 14900.0 1
Solute carrier organic anion transporter family member 1B3
CHEMBL1743121
Ki 4.59 4.59 25600.0 1

Pharmacokinetic Data

Parameter Value Units Species
CL 0.38 mL.min-1.kg-1 Rattus norvegicus
CL 0.0325 mL.min-1.kg-1 Rattus norvegicus
CL 0.335 mL.min-1.kg-1 Rattus norvegicus
CL 0.001167 mL.min-1.kg-1 Rattus norvegicus
CL 0.2267 mL.min-1.kg-1 Rattus norvegicus
CL 0.55 mL.min-1.kg-1 Rattus norvegicus
CL 1.288 mL.min-1.kg-1 Mus musculus
CL 0.92 mL.min-1.kg-1 Mus musculus
CL 0.5717 mL.min-1.kg-1 Rattus norvegicus
CL 0.03967 mL.min-1.kg-1 Rattus norvegicus
CL 0.7467 mL.min-1.kg-1 Rattus norvegicus
Cmax 40000.0 nM Mus musculus
Vd 0.0411 L.kg-1 Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Thrombopoietin receptor EC50 = 38.0 nM 7.42 Agonist activity at human thrombopoietin receptor expressed in mouse Ba/F3 cells... 18783949
Thrombopoietin receptor EC50 = 38.0 nM 7.42 Agonist activity at human thrombopoietin receptor in Ba/F3 cells assessed as act... 18778936
Voltage-gated inwardly rectifying potassium channel KCNH2 IC50 = 630.96 nM 6.2 Inhibition of rapid delayed inward rectifying potassium current (IKr) measured u... 25087753
Voltage-gated inwardly rectifying potassium channel KCNH2 IC50 = 690.0 nM 6.16 Inhibition of human ERG channel tail current 26935940
Broad substrate specificity ATP-binding cassette transporter ABCG2 IC50 = 3100.0 nM 5.51 Inhibition of human ABCG2 expressed in dog MDCK-II-BCRP cells membrane vesicles ... 35483322
METTL3/METTL14 IC50 = 3650.0 nM 5.44 Inhibition of METTL3/METTL14 (unknown origin) by bioluminescence assay 36692498
METTL3/METTL14 IC50 = 3650.0 nM 5.44 Inhibition of human recombinant METTL3/METTL14 extracted from baculovirus infect... 39291017
METTL3/METTL14 IC50 = 4550.0 nM 5.34 Inhibition of METTL3/METTL14 (unknown origin) by mass spectrometry-based assay 36692498
SARS-CoV-2 IC50 = 8270.0 nM 5.08 Antiviral activity against SARS-CoV-2 (viral titer) measured by plaque assay in ... -
Solute carrier organic anion transporter family member 2B1 Ki = 8480.0 nM 5.07 Inhibition of OATP2B1-mediated [3H]estrone-3-sulfate uptake in human OATP2B1 exp... 21422191
METTL3/METTL14 Kd = 13200.0 nM 4.88 Binding affinity to METTL3/METTL14 (unknown origin) assessed as dissociation con... 36692498
N6-adenosine-methyltransferase catalytic subunit Kd = 13200.0 nM 4.88 Binding affinity to METTL3 (unknown origin) assessed as dissociation constant by... 38805939
Solute carrier organic anion transporter family member 1B1 Ki = 14900.0 nM 4.83 Inhibition of OATP1B1-mediated [3H]estrone-3-sulfate uptake in human OATP1B1 exp... 21422191
Solute carrier organic anion transporter family member 1B3 Ki = 25600.0 nM 4.59 Inhibition of OATP1B3-mediated [3H]estradiol 17beta-glucuronide uptake in human ... 21422191

Literature References

PubMed DOI Target Context # Activities
21422191 10.1124/dmd.110.037960 Hepatocyte 17
21422191 10.1124/dmd.110.037960 ADMET 10
21422191 10.1124/dmd.110.037960 Rattus norvegicus 4
21422191 10.1124/dmd.110.037960 Liver 4
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
21422191 10.1124/dmd.110.037960 Solute carrier family 22 member 1 3
21422191 10.1124/dmd.110.037960 Solute carrier organic anion transporter family member 1B3 3
21422191 10.1124/dmd.110.037960 Solute carrier organic anion transporter family member 2B1 3
21422191 10.1124/dmd.110.037960 Solute carrier organic anion transporter family member 1B1 3
36692498 10.1021/acs.jmedchem.2c01601 METTL3/METTL14 3
25087753 10.1016/j.vascn.2014.07.002 Voltage-gated inwardly rectifying potassium channel KCNH2 3
25087753 10.1016/j.vascn.2014.07.002 Voltage-gated potassium channel, IKs; KCNQ1(Kv7.1)/KCNE1(MinK) 2
25087753 10.1016/j.vascn.2014.07.002 Sodium channel protein type 5 subunit alpha 2
25087753 10.1016/j.vascn.2014.07.002 Voltage-dependent L-type calcium channel subunit alpha-1C 2
- 10.6019/CHEMBL4495565 Vero C1008 2
21422191 10.1124/dmd.110.037960 Kidney 2
21422191 10.1124/dmd.110.037960 Mus musculus 2
18778936 10.1016/j.bmcl.2008.08.068 Thrombopoietin receptor 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
18783949 10.1016/j.bmcl.2008.08.077 Thrombopoietin receptor 2

Data from ChEMBL 36 via Core Engine